Our Recommendations
- Dementia mhGAP module (2017)
- Depression: Powerpoint Presentation slides (mhGAP) (2015)
- Pharmacological interventions in adolescents with psychotic disorders (2015)
- MhGAP Child and adolescent mental and behavioural disorders, slides. (2010)
- Other significant mental health complaints: mhGAP Training of Health-care Providers and training manual, supporting material (2015)
New Publications
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- EQUIP - Ensuring Quality in Psychological Support (2022)
Filter
63
Featured
Recommendations
14
New Publications
5
Language
Document type
No document type
43
Training Material
10
Manuals
6
Fact sheets
3
Resource Platforms
1
Countries / Regions
Western and Central Europe
1
Russia
1
Authors & Publishers
Publication Years
Category
Mobile Training Tools & Apps
1
Training Manuals
1
Toolboxes
Training Supporting Material mhGAP
63
Mental Health GAP Action Programme
43
Neurological Disorders
11
Depression
10
Children/Adolescents Mental Disorders
9
Mental disorders, others
9
Epilepsy
8
Mental Disorders
8
Schizophrenia
6
mhGAP Guides
4
Bipolar Affective Disorders
4
others
3
Substance Use Disorders & Addiction
3
Substance Use Disorders, Others
2
Epilepsy
2
Alzheimer's Disease & Dementia
2
Neurological disorders, Others
2
Psychosocial Support (MHPSS)
1
Mental Health
1
Training Manuals
1
Women's Mental Health
1
Mental Health Online Resources
1
MHPSS – Psychosocial Support
1
Psychosocial Support
1
Psychosocial Support
1
Modules
1
Self-harm & Suicide
1
Psychosocial Support
1
MHPSS Guidelines
1
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
Q5.SCOPING QUESTION: In individuals with psychotic disorders (including schizophrenia) who require long-term antipsychotic treatment, what is the safety and role of depot antipsychotic medication?
Q10: In individuals with psychotic disorders (including schizophrenia) and bipolar disorders are psychoeducation, family interventions and cognitive-behavioural therapy feasible and effective?
Q7: In individuals with bipolar mania, are a) antipsychotics, b) mood stabilizers (lithium carbonate, valproate, and carbamazepine) effective and safe
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
Q 4: Is behavioural activation better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with de...
Q6: Is advice on physical activity better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder with inactive lifestyles
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
Second-generation antipsychotic medications for psychotic disorders (including schizophrenia)
recommended
Q14. SCOPING QUESTION: In adults with psychotic disorders (including schizophrenia), what is the comparative effectiveness and safety of second-generation antipsychotic medications?
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
[Updated 2015]
Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefits and/or harm when compared to comparator?
В этом разделе «Руководства mhGAP по принятию мер в отношении психических и неврологических расстройств» приведены рекомендации по оценке и оказанию помощи при ост...
What can you expect?
As a future facilitator your role will be to learn about the structure of mhGAP-IG, how to teach the materials and utilize opportunities to prastice facilitation and supervision skills.
As a supervisor your role will be to serve as a point of reference for non-specialized heal...
